Cancer Research Cancer Epigenetics  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 21, 560-566, May 1, 1961]
© 1961 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trams, E. G.
Right arrow Articles by Smith, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trams, E. G.
Right arrow Articles by Smith, P. K.

On the Mechanism of Action of the Alkylating Agents. I. Interaction of Alkylating Agents with Nucleic Acids*

Eberhard G. Trams{dagger}, Moreshwar V. Nadkarni{dagger} and Paul K. Smith

( Department of Pharmacology, George Washington University, School of Medicine, Washington, D.C.)

The incorporation of isotopic ethylene-C14-imino-s-triazine (TEM), Myleran, chlorambucil, and sulfur mustard into the DNA fraction of regenerating liver and of various mouse ascites lymphomas was measured. The in vivo incorporation of these alkylating agents was estimated to be of the order of 1 mole of drug per mole of DNA polymer. Results obtained by several different methods of isolation of DNA from in vivo-treated tissues failed to show marked differences in the amounts of isotope coupled to DNA. No correlation was apparent between the susceptibility of the various tumors and the relative amounts of isotope incorporated into tumor DNA fractions. Pretreatment of tumor with nonlabeled triethylene melamine (TEM) failed to alter incorporation patterns for labeled TEM. It was concluded that attack on the DNA itself does not necessarily represent the mechanism of action by which the alkylating agents exert their cytostatic or cytotoxic effects.

* Aided by grants from the Damon Runyon Memorial Fund for Cancer Research (DRIR-42), The American Cancer Society (T-14), and the Atomic Energy Commission (AT-(30-1)-1107).

Part of this material was presented in abstract at the VIIth International Cancer Congress, London, 1958.

{dagger} Present address: National Institutes of Health, Bethesda, Md.

Received 10/31/60.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1961 by the American Association for Cancer Research.